xchè contava qualcosa sto presidente che non contava nulla ! QUESTI SONO SOLO RIEMPITIVI , LA CELLTHERAPEUTICS è SOLO JAMES BIANCO A LIVELLO AMMINISTRATIVO ! IL RESTO STANNO Lì PER UN TOZZO DI PANE REGALATO ! COMPRESO QUESTO CHE PRENDERA' IL POSTO ! LE AZIONI SONO TRIDIMENSIONALI , X CUI LASCIA IL TEMPO CHE TROVA CHI ENTRA O CHI ESCE ! LA FINANZA è SOLO FANTASIA MALATA DI 7 O 8 PSICOPATICI ! L'AMERICA ANDRA' A FINIRE COME UN PAESE DA TERZO MONDO ! A CHI VENDE COSTUI LE MOLECOLE TANTO DECANTATE ? PURTROPPO LA NUDA VERITA' è UN ALTRA : SUL PIANETA TERRA ORMAI SIAMO TROPPI ! è CHI COMANDA HA DECISO DI CANCELLARE OLTRE I DUE TERZI DI ABITANTI ! QUESTO è !
![Frown :( :(](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
CHI SI AFFANNA A DIRE ALTRO (INFORMAZIONE IN GENERE), RIMANE SOLO UNO SCIACQUINO AL GUINZAGLIO DI QUESTI 7 O 8 PSICOPATICI.
E se fossero "dei cavalli di Troia"............ proprio nel momento in cui le CAPACITA' ORGANIZZATIVE/rete di vendita........... di Philips dovevano tornare Utitli............. VIA
Philips, Craig
Brief Biography
Mr. Craig W. Philips is no longer President of Cell Therapeutics Inc., effective July 16, 2012. In that role, he managed the company's day-to-day drug development and commercial operations. Mr. Philips provided services to the company as a consultant from April 2008 until he assumed the position of President. Prior to joining the company, Mr. Philips was Vice President and General Manager of Bayer Healthcare Oncology from December 2006 to April 2008. Prior to Bayer Healthcare, Mr. Philips was Vice President and General Manager of Berlex Oncology from October 2004 to December 2006. He was also with Schering Plough from 1989 to 2003 in a variety of commercial and general management positions in the U.S., Canada, Southeast Asia and Australia. From 1984 to 1989 he was with Bristol Myers in a variety of commercial roles. Mr. Philips has also served as a member or a chair of the alliance executive committees, which included Onyx, Novartis, Genzyme, and Favrille. Mr. Philips received his B.Sc. in marketing and M.B.A. from Ohio State University.
Benner, Steven
Brief Biography
Dr. Steven E. Benner, M.D., M.H.S., has been appointed as Executive Vice President, Chief Medical Officer of Cell Therapeutics, Inc., effective June 14, 2012. Dr. Benner was previously senior vice president and chief medical officer at OncoMed, a venture-backed biotechnology company focused on the development of cancer stem cell targeting agents. Prior to OncoMed, he was CMO at Protein Design Labs ("PDL"), where he was accountable for all development activities including clinical development, clinical operations, biometry, regulatory affairs, and safety. He also served as Chair of the Portfolio and Clinical Development Management Committees of PDL. Before PDL he held several senior executive roles at Bristol-Myers Squibb in global development, life cycle management, and licensing and alliances.